MMNGX | PMAQX | MMNGX / PMAQX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 2 years | 8 years | - |
Gain YTD | 15.253 | 26.395 | 58% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 100000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 5.16B | 30B | 17% |
Annual Yield % from dividends | 0.00 | 0.10 | - |
Returns for 1 year | 20.94 | 32.12 | 65% |
Returns for 3 years | N/A | 6.88 | - |
Returns for 5 years | N/A | 55.10 | - |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GARSX | 9.93 | N/A | N/A |
Goldman Sachs Global Rl Estt Secs Instl | |||
BRUHX | 17.84 | N/A | N/A |
MFS Blended Research Value Equity I | |||
NAMAX | 15.21 | -0.03 | -0.20% |
Columbia Select Mid Cap Value Instl | |||
MINJX | 40.72 | -0.36 | -0.88% |
MFS International Intrinsic Value R6 | |||
FBDIX | 146.81 | -2.01 | -1.35% |
Franklin Biotechnology Discovery A |